Iroko Pharmaceuticals to Present at the UBS 2014 Global Healthcare Conference

PHILADELPHIA, MAY 13, 2014 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company will be presenting at the 2014 Global Healthcare Conference, sponsored by UBS, taking place at the Sheraton New York Times Square Hotel, in New York City. Iroko’s President and CEO, John Vavricka, will present on Tuesday, May 20, 2014, at 4:00 p.m. Eastern Time.

About Iroko Pharmaceuticals, LLC

Iroko is a global specialty pharmaceutical company, based in Philadelphia, dedicated to advancing the science of analgesia. The company develops and globally commercializes pharmaceutical products. In addition to the Iroko products that are marketed worldwide, the company has a robust pipeline of investigational low dose NSAID products being developed using iCeutica Inc.’s proprietary SoluMatrix Fine Particle Technology™. For more information, visit


Jessica Donnelly for Iroko Pharmaceuticals, LLC, 212-798-9819

Kate de Santis, Iroko Pharmaceuticals, LLC, 267-546-1682

SoluMatrix Fine Particle Technology™ is a trademark of iCeutica Inc., and is licensed to Iroko for exclusive use in NSAIDs.